Page last updated: 2024-10-29

indirubin-3'-monoxime and Neurodegenerative Diseases

indirubin-3'-monoxime has been researched along with Neurodegenerative Diseases in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sathiya Priya, C1
Vidhya, R1
Kalpana, K1
Anuradha, CV1

Other Studies

1 other study available for indirubin-3'-monoxime and Neurodegenerative Diseases

ArticleYear
Indirubin-3'-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain.
    International immunopharmacology, 2019, Volume: 70

    Topics: Amyloid beta-Peptides; Animals; Apoptosis; Brain; Diet, High-Fat; Disease Models, Animal; Fructose;

2019